According to Calithera Biosciences 's latest financial reports the company's current earnings (TTM) are -$39.65 M. In 2021 the company made an earning of -$0.12 B a decrease over its 2020 earnings that were of -$90.14 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | -$39.65 M | -65.55% |
2021 | -$0.12 B | 27.68% |
2020 | -$90.14 M | 0.31% |
2019 | -$89.86 M | 64.49% |
2018 | -$54.63 M | 96.32% |
2017 | -$27.83 M | -26.78% |
2016 | -$38.01 M | 16.42% |
2015 | -$32.65 M | 50.35% |
2014 | -$21.72 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | $6.85 B | -17,398.87% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | -$79.39 M | 100.22% | ๐บ๐ธ USA |
Aeterna Zentaris AEZS | -$18.01 M | -54.58% | ๐บ๐ธ USA |